The FDA has approved an oral tablet formulation of sodium sulfate, magnesium sulfate, and potassium chloride (Sutab – Braintree) for colon cleansing prior to colonoscopy in adults. A sodium sulfate-based oral solution (Suprep) has been available in the US since 2010. Sutab is the second tablet formulation to be approved for bowel cleansing prior to colonoscopy; a sodium phosphate-based tablet (OsmoPrep) was approved earlier.
COLONOSCOPY PREPARATIONS — Traditional polyethylene glycol (PEG) plus electrolytes solutions for bowel cleansing prior to colonoscopy are isotonic and require patients to ingest up to 4 L of fluid to produce a cathartic effect....
RELEASE
The FDA has issued an Emergency Use Authorization (EUA) for Lilly's investigational monoclonal antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) to be administered together by IV infusion for treatment of mild to moderate COVID-19 in adults and pediatric patients (aged ≥12 years and weighing ≥40 kg) who are at high risk of progressing to severe disease and/or hospitalization ...
